Jiangsu Hengrui Medicine
600276.SS
#511
Rank
โ‚น3.508 T
Marketcap
โ‚น550.00
Share price
-0.09%
Change (1 day)
8.83%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2023 (TTM): โ‚น7.46

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is โ‚น7.93. In 2022 the company made an earnings per share (EPS) of โ‚น7.91 a decrease over its 2021 EPS that were of โ‚น9.54.

EPS history for Jiangsu Hengrui Medicine from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น7.46-5.68%
2022โ‚น7.91-17.1%
2021โ‚น9.54-24.44%
2020โ‚น12.6220.3%
2019โ‚น10.4925.58%
2018โ‚น8.3627.55%
2017โ‚น6.5521.64%
2016โ‚น5.3913.57%
2015โ‚น4.7439.86%
2014โ‚น3.3921.33%
2013โ‚น2.7917.7%
2012โ‚น2.3725.56%
2011โ‚น1.8926.22%
2010โ‚น1.5010.3%
2009โ‚น1.3657.92%
2008โ‚น0.8611.06%
2007โ‚น0.7785.81%
2006โ‚น0.4287.94%
2005โ‚น0.2233.97%
2004โ‚น0.1729.78%
2003โ‚น0.1319.78%
2002โ‚น0.11